Cargando…
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing
Recent advances and discoveries in the structure and role of mRNA as well as novel lipid-based delivery modalities have enabled the advancement of mRNA therapeutics into the clinical trial space. The manufacturing of these products is relatively simple and eliminates many of the challenges associate...
Autores principales: | Youssef, Maryam, Hitti, Cynthia, Puppin Chaves Fulber, Julia, Kamen, Amine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604719/ https://www.ncbi.nlm.nih.gov/pubmed/37892179 http://dx.doi.org/10.3390/biom13101497 |
Ejemplares similares
-
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
por: Yang, Zeyu, et al.
Publicado: (2023) -
Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures
por: Fulber, Julia Puppin Chaves, et al.
Publicado: (2021) -
Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
por: Fulber, Julia P. C., et al.
Publicado: (2022) -
Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
por: Milián, Ernest, et al.
Publicado: (2015) -
mRNA vaccines manufacturing: Challenges and bottlenecks
por: Rosa, Sara Sousa, et al.
Publicado: (2021)